Pomerantz Law Firm Files Class Action Against 3D Systems Over Securities Violations

Pomerantz Law Firm Files Class Action Against 3D Systems



On June 27, 2025, Pomerantz LLP announced the initiation of a class action lawsuit against 3D Systems Corporation, a significant player in the additive manufacturing industry, as well as certain individuals from its executive team. This lawsuit, filed in the United States District Court for the District of Delaware, pertains to securities law violations affecting investors who acquired 3D Systems securities between August 13, 2024, and May 12, 2025.

Background of the Case


The class action aims to represent individuals and entities that purchased 3D Systems securities within the designated time frame and seeks to recover damages attributed to the alleged misconduct by the company's executives. The lawsuit cites violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Investors have until August 12, 2025, to apply for lead plaintiff status in the case.

Danielle Peyton, a representative from Pomerantz, encourages individuals impacted by these events to reach out for more information and inclusion in the legal proceedings.

3D Systems operates globally, providing solutions for 3D printing and digital manufacturing. The company is organized into two main segments: Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment covers numerous applications, including dental products, medical devices, and personalized health services—part of their ambitious Regenerative Medicine Program aimed at pioneering organ transplants via 3D printing technology.

Since its partnership with United Therapeutics Corporation in 2018, 3D Systems has aimed high, with the ultimate goal of 3D printing lungs to assist patients suffering from terminal lung disease. This collaboration involves specific milestones that must be achieved for the project to progress, and the company has continued to adapt its strategies as methods for testing evolve. However, changes to these milestone criteria late in 2024 raised concerns about the subsequent impact on revenues from the Regenerative Medicine initiative.

Industry Challenges and Company Performance


Despite a noted decline in customer expenditure leading to diminishing sales across the 3D printing sector, 3D Systems has expressed optimism regarding its financial future. The firm's leadership has consistently emphasized a commitment to innovating and enhancing product offerings, even amidst adversity in the global market.

However, the reality of their fiscal performance paints a different picture. In March 2025, the company presented its financial outlook for 2025, revealing expectations for revenues between $420 million and $435 million, which suggested minimal growth compared to previous figures. Non-GAAP gross profit margins were projected at 37% to 39%, and operating expenses were estimated to fall between $200 million to $220 million, with the goal of achieving break-even adjusted EBITDA by Q4 2025.

Unfortunately, further disclosures indicated a troubling trend: in Q4 2024, the company reported disappointing financial outcomes, with earnings per share significantly missing consensus estimates, alongside alarming declines in revenue and outlays attributed to broader macroeconomic factors. Reports indicated a sharp $9 million drop in Q4 revenues related to accounting changes in their Regenerative Medicine program.

Prior to the class action, 3D Systems encountered dramatic stock price fluctuations, with shares plummeting 20.96% after negative earnings reports were released. On May 12, 2025, the company withdrew its positive forecast for 2025 following additional disappointing results indicating continued operational losses. On the back of such announcements, stock values dropped further, inciting further scrutiny from analysts who questioned the company’s viability moving forward.

Legal Representation and Future Implications


With over 85 years of experience, Pomerantz LLP is established as a leading firm in corporate and securities class action litigations. Their history is marked by successful litigation on behalf of those harmed by fraud and corporate misconduct, securing billions in damages for their clients.

As this case unfolds, investors in 3D Systems and observers of the 3D printing market will be watching closely not only for the outcome of this legal action but also for how the company plans to navigate its ongoing operational challenges. Questions surrounding accountability and transparency in corporate governance will likely come to light as the situation develops.

For more information regarding joining the class action or for any inquiries, investors are encouraged to contact Danielle Peyton at Pomerantz LLP directly.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.